Skip to content
Menu

Standard BioTools Inc. LAB

Full chart Compare
Set alert

Price alert · LAB

All alert types
0.61 USD +0.04 (+7.67%)

Regular-session close

0.63 +0.02 +2.97%

After hours · Nov 19, 4:00 PM ET

0.562 Day range 0.6302
0.39 52-week range 1.72
YTD
-52.05%
1 year
-52.05%

Analyst view

Price target (mean) 3.08 +402.4% upside
Target (low)
2.50
Target (mean)
3.08
Target (high)
4.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 3

Included in Essentials and up

Sign in to see Revenue and earnings forecast

Reported revenue and earnings per share by year, then what analysts expect next.

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LAB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.03-0.03 – -0.03-0.12103+75.2%43.03M+52.7%2
Next quarter-0.04-0.04 – -0.04-0.2381+83.2%45.60M+0.1%1
Current year-0.215-0.24 – -0.19-0.55157+61.0%171.20M+61.0%2
Next year-0.155-0.16 – -0.15-0.215+27.9%188.17M+9.9%2

Upgrades and downgrades

The latest rating changes

LAB analyst upgrades and downgrades
DateFirmActionFromTo
Oct 31, 2024TD CowenMaintainedBuyBuy
Aug 1, 2024TD CowenMaintainedBuyBuy
Apr 16, 2024TD CowenInitiated—Buy
Apr 4, 2024JefferiesInitiated—Buy
Jul 12, 2023KeybancInitiated—Overweight

Included in Plus and up

Sign in to see Analyst trend

Two years of the analyst rating mix and the average price target against the price.